These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 17028522)

  • 1. [Follow-up of osteoporosis treatment].
    Lespessailles E
    Presse Med; 2006 Oct; 35(10 Pt 2):1565-70. PubMed ID: 17028522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Osteoporosis: Optimizing treatment strategy].
    Thomas T
    Presse Med; 2006 Oct; 35(10 Pt 2):1543-6. PubMed ID: 17028519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Osteoporosis priority: Reduce the number of fractures].
    Roux C
    Presse Med; 2006 Oct; 35(10 Pt 2):1527-8. PubMed ID: 17028516
    [No Abstract]   [Full Text] [Related]  

  • 4. Importance of alfacalcidol in clinical conditions characterized by high rate of bone loss.
    Reginster JY; Lecart MP; Richy F
    J Rheumatol Suppl; 2005 Sep; 76():21-5. PubMed ID: 16142847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examining the relationship between bone mineral density and fracture risk reduction during pharmacologic treatment of osteoporosis.
    Divittorio G; Jackson KL; Chindalore VL; Welker W; Walker JB
    Pharmacotherapy; 2006 Jan; 26(1):104-14. PubMed ID: 16506352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical points in strategies for the diagnosis and treatment of osteoporosis.
    Lorenc RS; Misiorowski W; Karczmarewicz E
    Endokrynol Pol; 2009; 60(2):124-33. PubMed ID: 19396756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug treatment of postmenopausal osteoporosis. What's New in 2006].
    Roux C; Briot K; Dumarcet N; Bourgoin M; Chapurlat R; Christin-Maitre S; Cortet B; Costagliola D; Diebolt V; Lacoin F; Letombe B; Oberlin F; Orcel P; Ravaud P; Seret P; Thomas T; Vogel JY; Barna A; Nouyrigat E; Veyries ML; Yoldjian I
    Presse Med; 2006 Oct; 35(10 Pt 2):1529-39. PubMed ID: 17028517
    [No Abstract]   [Full Text] [Related]  

  • 8. Three-year denosumab treatment in postmenopausal Japanese women and men with osteoporosis: results from a 1-year open-label extension of the Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT).
    Sugimoto T; Matsumoto T; Hosoi T; Miki T; Gorai I; Yoshikawa H; Tanaka Y; Tanaka S; Fukunaga M; Sone T; Nakano T; Ito M; Matsui S; Yoneda T; Takami H; Watanabe K; Osakabe T; Okubo N; Shiraki M; Nakamura T
    Osteoporos Int; 2015 Feb; 26(2):765-74. PubMed ID: 25403903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial.
    Black DM; Schwartz AV; Ensrud KE; Cauley JA; Levis S; Quandt SA; Satterfield S; Wallace RB; Bauer DC; Palermo L; Wehren LE; Lombardi A; Santora AC; Cummings SR;
    JAMA; 2006 Dec; 296(24):2927-38. PubMed ID: 17190893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of absolute bone mineral density in the assessment of antiresorptive agents used for the prevention of osteoporotic fractures.
    Kuroda T; Shiraki M; Shiraki Y; Tanaka S
    J Clin Densitom; 2012; 15(4):392-398. PubMed ID: 22521539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Osteoporosis and the orthopaedic surgeon in 2007].
    Féron JM; Thomas T; Roux C; Puget J
    Rev Chir Orthop Reparatrice Appar Mot; 2008 Oct; 94 Suppl(6):S99-107. PubMed ID: 18928797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
    Ettinger MP
    Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early changes in biochemical markers of bone turnover predict bone mineral density response to antiresorptive therapy in Korean postmenopausal women with osteoporosis.
    Kim SW; Park DJ; Park KS; Kim SY; Cho BY; Lee HK; Shin CS
    Endocr J; 2005 Dec; 52(6):667-74. PubMed ID: 16410657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different effects of antiresorptive therapies on vertebral and nonvertebral fractures in postmenopausal osteoporosis.
    Delmas PD
    Bone; 2002 Jan; 30(1):14-7. PubMed ID: 11792559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-year follow-up of 215 fracture patients from a prospective and consecutive osteoporosis screening program. Fracture patients care!
    Astrand J; Thorngren KG; Tägil M; Akesson K
    Acta Orthop; 2008 Jun; 79(3):404-9. PubMed ID: 18622846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoporosis and fracture risk in older people.
    Coughlan T; Dockery F
    Clin Med (Lond); 2014 Apr; 14(2):187-91. PubMed ID: 24715132
    [No Abstract]   [Full Text] [Related]  

  • 17. Anabolic skeletal therapy for osteoporosis.
    Girotra M; Rubin MR; Bilezikian JP
    Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):745-54. PubMed ID: 17117299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electronic medical record reminder improves osteoporosis management after a fracture: a randomized, controlled trial.
    Feldstein A; Elmer PJ; Smith DH; Herson M; Orwoll E; Chen C; Aickin M; Swain MC
    J Am Geriatr Soc; 2006 Mar; 54(3):450-7. PubMed ID: 16551312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers for osteoporosis management: utility in diagnosis, fracture risk prediction and therapy monitoring.
    Garnero P
    Mol Diagn Ther; 2008; 12(3):157-70. PubMed ID: 18510379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Osteoporosis: prevention of bone loss and fractures].
    Pfeifer M; Begerow B; Pollähne W; Minne HW
    MMW Fortschr Med; 2002 Nov; 144(48):I-VIII; quiz IX-X. PubMed ID: 12532553
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.